Skip to main content
OpenTrials

Clinical trial condition

Stage IV Lung Non-Small Cell Cancer AJCC v7

Explore clinical trials studying Stage IV Lung Non-Small Cell Cancer AJCC v7. Study availability and eligibility vary by location and protocol.

16 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Stage IV Lung Non-Small Cell Cancer AJCC v7 trial results

Recruiting

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

NCT03191149

Conditions
Advanced Lung Non-Small Cell Carcinoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 345 locations
View Trial Details
Completed

Erlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer

NCT02535338

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Keck Medical Center of USC Pasadena Pasadena, California, United States
View Trial Details
Completed

Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer

NCT02520778

Conditions
Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7, +3 more
Locations
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Moffitt Cancer Center-International Plaza Tampa, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 18 locations
View Trial Details
Completed

Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer

NCT03468985

Conditions
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 468 locations
View Trial Details
Completed

Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations

NCT01532089

Conditions
EGFR Exon 19 Deletion Mutation, EGFR NP_005219.2:p.L858R, Lung Non-Squamous Non-Small Cell Carcinoma, +1 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Heartland Cancer Research NCORP Decatur, Illinois, United States
  • Illinois CancerCare-Peoria Peoria, Illinois, United States
  • Carle Cancer Center NCI Community Oncology Research Program Urbana, Illinois, United States
View all 19 locations
View Trial Details
Completed

Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

NCT00126581

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +20 more
Locations
  • East Bay Radiation Oncology Center Castro Valley, California, United States
  • Eden Hospital Medical Center Castro Valley, California, United States
  • Valley Medical Oncology Consultants-Castro Valley Castro Valley, California, United States
  • Bay Area Breast Surgeons Inc Emeryville, California, United States
View all 96 locations
View Trial Details
Active, Not Recruiting

Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer

NCT02888743

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 42 locations
View Trial Details

Related conditions